To make matters worse, since 1999 the National Health Insurance system has adjusted drug prices once every two years, and with the system chronically underfunded, "price adjustments" in practice have meant "price reductions." If the price cuts are just a bit steep, domestic pharmaceuticals firms get hit hard.
雪上加霜的是，自 1999 年起，全民健保制度每 2 年進行一次藥價調整；在健保年年入不敷出的現實下，所謂「調整」，絕大部分是往下修正，只要砍得重一點，國內製藥廠商就會大失血。